Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)

Samankaltaisia teoksia

• Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients
  Tekijä: Jaiswal, Shikha, et al.
  Julkaistu: (2017)
• Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670)
  Tekijä: Di Tucci, Anna Angela, et al.
  Julkaistu: (2007)
• Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major
  Tekijä: Pathare, Anil, et al.
  Julkaistu: (2009)
• Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
  Tekijä: Taher, Ali, et al.
  Julkaistu: (2009)
• Iron Excretion in Thalassaemia Major After Administration of Chelating Agents
  Tekijä: Smith, R. Sephton
  Julkaistu: (1962)